1. The authors acknowledged the limitation of nasopharyngeal swabs in predicting etiology of lower respiratory tract infections. Lung aspirates have been extensively used in other settings and this clearly offers a better reflection of likely etiology of lower respiratory infections. Some comments in this protocol as to why this approach is not being adopted will be helpful.
2. while radio logically confirmed pneumonia is the gold standard for pneumonia diagnosis, there is no clear description in the protocol of how the films will be read and what features will constitute pneumonia. There is no description of how chest radiographs will be read.
3. The sample size calculations are based on published reports from other settings. In the absence of local prevalence data on carriage, this will be acceptable, but there should be acknowledgement that should the prevalence of nasopharyngeal respiratory pathogens differ significantly at this location, the study may be under-powered to address the proposed aims.
I would like to list some points to be addressed by the authors before acceptance:
1) The most recent estimate of number of children´s death per year due to pneumonia is 1 million. Please, check this information in the literature and correct the figures provided in the Introduction.
2) Among the Limitations, the authors need to address that NOT always presence in the upper respiratory tract implies presence in the lower respiratory tract.
3) Please, proofread the manuscript to correct typos; for example: "...higher pneumococcal load compared..." instead of compare; Haemophilus influenzae instead of influenza, etc.
3) The authors need to use appropriately the expression "virusbacterial co-infection" ADN virus-bacterial co-detection; please, observe that according to the Methods, it will be possible to report DETECTION and it may be possible to infer INFECTION for specific pathogens -not for all of them. Therefore, this is a crucial issue in this study and therefore in this manuscript.
4) The patients/controls age range is very wide (< 18 years). It should be advisable to study the same number of patients/controls in different age strata: < 5 years, 6-10 years, 11-17 years -as the nasopharyngeal microbiota changes during children´s growth. Your sample size is optimal for a group of patients/controls with a stable microbiota.
VERSION 1 -AUTHOR RESPONSE
Reviewers' Comments to Author:
Reviewer: 1 Reviewer Name: Stephen Obaro Overall, a well written protocol for the evaluation of etiologic agents of community acquired pneumonia in children in the post vaccination era with pneumococcal conjugate vaccine. This is an important research question that could potentially provide very meaningful information for developing new strategies for pneumonia prevention in children.
Author's response to reviewer 1: We thank the reviewer for their encouraging review Comments 1. The authors acknowledged the limitation of nasopharyngeal swabs in predicting etiology of lower respiratory tract infections. Lung aspirates have been extensively used in other settings and this clearly offers a better reflection of likely etiology of lower respiratory infections. Some comments in this protocol as to why this approach is not being adopted will be helpful.
Response: We agree with the reviewer that lung aspirate remains the most sensitive and specific diagnostic procedure to determine the aetiology of pneumonia. The major challenge is the invasive nature of this specimen with its attendant risks -as such, it has not been included in recent aetiology studies (Jain et al NEJM 2015) nor in national guidelines (Bradley et al CID 2011) . We have revised the "specimen collection" part (see page 7) to include reviewer's suggestion.
2. While radiologically confirmed pneumonia is the gold standard for pneumonia diagnosis, there is no clear description in the protocol of how the films will be read and what features will constitute pneumonia. There is no description of how chest radiographs will be read.
Response: We have used a pragmatic definition of radiologically -confirmed pneumonia (alveolar consolidation as determined by the treating physician) facilitating recruitment after hours (ie when a radiologist is not available to review the chest xray). Xrays are all reviewed by paediatric radiologist and formal x-ray reports stored. The manuscript has been amended to reflect this clarification (page 6).
Response: We agree with the reviewer that the prevalence of nasopharyngeal pathogens could vary by settings. We have used studies conducted in Finland and Australia as reference for our sample size calculation, settings similar to the study. We therefore remain confident that we will not be underpowered to address the primary aim. However, we suspect that we could be less -powered to run the regression analysis for one of our secondary aims: the relationship between disease severity and outcome and presence of multiple pathogens. Will only run those analysis if the number permits (see page 8).
Response: We agree with the reviewer and have revised the limitation section (page 3) to address reviewer's concern 3) Please, proofread the manuscript to correct typos; for example: "...higher pneumococcal load compared..." instead of compare; Haemophilus influenzae instead of influenza, etc.
Response: The manuscript has been proof read to ensure any typos and missing references (see page 5, 8, 11).
3) The authors need to use appropriately the expression "virus -bacterial co-infection" AND virusbacterial co-detection; please, observe that according to the Methods, it will be possible to report DETECTION and it may be possible to infer INFECTION for specific pathogens -not for all of them. Therefore, this is a crucial issue in this study and therefore in this manuscript.
Response: We acknowledge the reviewer's concern regarding the expression "detection" and "infection" and agree with the reviewer that the pathogens that would be detected might not be always infective. For instances, the pathogens that we would detect in healthy children might not be the cause of infection per se though these same pathogens have been identified in children with respiratory infection. We have followed the reviewer's suggestion and report the detection of viruses and bacteria and both, instead being infected.
Response: Thanks for your suggestion. We have already mentioned in the manuscript in "Identification and enrolment of study participants" under "Method" section that controls will be enrolled by frequency matched to cases in four different age groups, i.e. <1 year, 1-4 years, 5-9 years and > 10 years (see page 7) to adjust the effect of nasopharyngeal microbiota that varies with the age of participant.
VERSION 2 -REVIEW

REVIEWER
Cristiana M. Nascimento-Carvalho Federal University of Bahia School of Medicine, Brazil REVIEW RETURNED 07-Feb-2018
GENERAL COMMENTS
The authors have addressed the previously raised issues.
